Yokukansan, a traditional Japanese herbal medicine, enhances the anxiolytic effect of fluvoxamine and reduces cortical 5-HT2A receptor expression in mice.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Ethnopharmacology

• Publication date

  2018-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jep.2018.01.032PMID 29382554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavioral Effects of Systemic, Infralimbic and Prelimbic Injections of a Serotonin 5-HT2A Antagonist in Carioca High- and Low-Conditioned Freezing Rats

  2017cited by this paper
• Yokukansan for the treatment of preoperative anxiety and postoperative delirium in colorectal cancer patients: a retrospective study

  2017cited by this paper
• Inhibitory effect of yokukansan on the decrease in the hippocampal excitatory amino acid transporter EAAT2 in stress-maladaptive mice

  2017cited by this paper
• AUGMENTATION STRATEGIES FOR TREATMENT‐RESISTANT ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META‐ANALYSIS

  2016cited by this paper
• Serotonin in fear conditioning processes.

  2015cited by this paper
• Yokukansan Increases 5-HT1A Receptors in the Prefrontal Cortex and Enhances 5-HT1A Receptor Agonist-Induced Behavioral Responses in Socially Isolated Mice

  2015cited by this paper
• Yokukansan, a traditional Japanese medicine, decreases head-twitch behaviors and serotonin 2A receptors in the prefrontal cortex of isolation-stressed mice.

  2015cited by this paper
• Neuroprotective effect of yokukansan against cytotoxicity induced by corticosterone on mouse hippocampal neurons.

  2014cited by this paper
• The Effect of the Kampo Medicine Yokukansan on Preoperative Anxiety and Sedation Levels

  2014cited by this paper
• Yokukansan, a traditional Japanese herbal medicine, alleviates the emotional abnormality induced by maladaptation to stress in mice.

  2014cited by this paper
• Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta‐analysis of randomized controlled trials

  2013cited by this paper
• Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice

  2013cited by this paper
• Regulating Prefrontal Cortex Activation: An Emerging Role for the 5-HT2A Serotonin Receptor in the Modulation of Emotion-Based Actions?

  2013cited by this paper
• Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice.

  2013cited by this paper
• Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats.

  2013cited by this paper
• Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin ₁A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan.

  2012cited by this paper
• Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system.

  2012cited by this paper
• Expression of microsomal prostaglandin E synthase-1 in the spinal cord in a transgenic mouse model of amyotrophic lateral sclerosis.

  2012cited by this paper
• Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.

  2012cited by this paper
• SSRIs and conditioned fear.

  2011cited by this paper
• Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells.

  2010cited by this paper
• Anxiolytic effect of a herbal medicine, yokukansan, in aged rats: involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex.

  2010cited by this paper
• A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.

  2009cited by this paper
• 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.

  2008cited by this paper
• Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex.

  2008cited by this paper
• Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats.

  2007cited by this paper
• Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT.

  2006cited by this paper
• Cortical 5-HT2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice

  2006cited by this paper
• Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats

  2005cited by this paper
• Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze

  2005cited by this paper
• Characterization of the anxiolytic-like effects of fluvoxamine, milnacipran and risperidone in mice using the conditioned fear stress paradigm.

  2004cited by this paper
• The medical benefit of 5-HT research.

  2002cited by this paper
• Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635.

  2002cited by this paper
• Molecular, pharmacological and functional diversity of 5-HT receptors.

  2002cited by this paper
• Rosmarinic acid and caffeic acid reduce the defensive freezing behavior of mice exposed to conditioned fear stress

  2002cited by this paper
• Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

  2000cited by this paper
• Pretreatment with diazepam suppresses the reduction in defensive freezing behavior induced by fluvoxamine in the conditioned fear stress paradigm in mice.

  2000cited by this paper
• Cellular and subcellular distribution of the serotonin 5‐HT2A receptor in the central nervous system of adult rat

  1999cited by this paper
• Conditional analgesia, defensive freezing, and benzodiazepines.

  1988cited by this paper

• Fluvoxamine Attenuates Blood–Brain Barrier Disruption in Drug-Resistance Epilepsy and inhibits Ferroptosis via the Sigma-1 Receptor-TAMM41 signaling in bEnd.3 cells

  2025cites this paper
• Kampo medicine in the management of menopausal symptoms: A narrative review of therapeutic potential.

  2025cites this paper
• The Serotonin-Mediated Anti-Allodynic Effect of Yokukansan on Paclitaxel-Induced Neuropathic Pain

  2024cites this paper
• Effective use of yokukansan for Caucasian patient with panic disorder: A case report

  2024cites this paper
• Analgesic effects of oral Yokukansan on acute postoperative pain and involvement of the serotonin nervous system: a mouse model study

  2024cites this paper
• Phytotherapy of abnormality of fear memory: A narrative review of mechanisms.

  2023cites this paper
• The effect of SSRIs on fear learning: a systematic review and meta-analysis

  2023cites this paper
• A review of frequently used Kampo prescriptions. Part 3. Yokukansan

  2023cites this paper
• Cnidium officinale Makino: Phytology, Phytochemistry, Toxicology, Pharmacology and Prescriptions (1967–2023)

  2023cites this paper
• Yokukansan Inhibits the Development of Morphine Tolerance by Regulating Presynaptic Proteins in DRG Neurons

  2022cites this paper
• Traditional uses, chemical compounds, pharmacological activities and clinical studies on the traditional Chinese prescription Yi-Gan San.

  2022cites this paper
• Mechanisms Underlying the Action of Ziziphi Spinosae Semen in the Treatment of Insomnia: A Study Involving Network Pharmacology and Experimental Validation

  2021cites this paper
• Influence of 5-HT2A receptor function on anxiety-like behavior induced by a combination treatment with doxorubicin and cyclophosphamide in rats

  2021cites this paper
• Pharmacological effects of yokukansan on behavioral and psychological symptoms of dementia

  2019cites this paper
• Effect of Yokukansan and Yokukansankachimpihange on Aggressive Behavior, 5-HT Receptors and Arginine Vasopressin Expression in Social Isolation-Reared Mice.

  2019cites this paper
• Potential Application of Yokukansan as a Remedy for Parkinson's Disease

  2018cites this paper